TheodoreLeslieDeWeeseMDFASTRO

Vice Dean for Clinical Affairs; President, Clinical Practice Association; Sidney Kimmel Professor of Radiation Oncology and Molecular Radiation Sciences; Professor of Oncology, Professor of Urology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. DeWeese is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. DeWeese's full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-8964

Fax+1 410-502-1419

Education & Training

Johns Hopkins University School of MedicineFellowship, 1994 - 1995
Johns Hopkins UniversityResidency, Radiation Oncology, 1991 - 1994
MedStar Franklin Square Medical CenterInternship, Internal Medicine, 1990 - 1991
University of Colorado School of Medicine Anschutz Medical CampusClass of 1990

Certifications & Licensure

MD State Medical License 1995 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2019
America's Top Doctors for Cancer Castle Connolly, 2005-2013, 2015-2019
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Join now to see all

Clinical Trials

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate Start of enrollment: 2008 Dec 22
Active, not recruiting
Phase 2
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer Start of enrollment: 2011 Sep 01
Active, not recruiting
Phase 3
Radiation and Androgen Ablation for Prostate Cancer Start of enrollment: 2013 May 22
Active, not recruiting
Phase 1, Phase 2
MRI for Assessing Prostate Cancer Response Start of enrollment: 2012 Nov 16
Recruiting
Not Applicable
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy Start of enrollment: 2015 Mar 28
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, Yang Song, Amol Shetty
Radiotherapy and Oncology. 2024-11-06
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
Mindy K Graham, Rulin Wang, Roshan Chikarmane, Bulouere Abel, Ajay Vaghasia
Nature Communications. 2024-08-28
1 citations
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer.
Philip Sutera, Matthew P Deek, Rebecca A Deek, Ozan Cem Guler, Pervin Hurmuz
Advances in Radiation Oncology. 2024-07-01

Journal Articles

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...
Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology

Press Mentions

Johns Hopkins and Family of Henrietta Lacks Break Ground on Building Named in Honor of Henrietta LacksOctober 28th, 2024
Brenda Banwell Named Pediatrician-in-Chief and Co-Director of Johns Hopkins Children’s CenterSeptember 9th, 2024
News & PublicationsMay 1st, 2024
Join now to see all